Clinical trial
A Combined Cell Therapy Approach to the Treatment of Neuroblastoma
NCT02745756 is registered in ClinicalTrials.gov with H. Lee Moffitt Cancer Center and Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Combined Cell Therapy Approach to the Treatment of Neuroblastoma
- Lead sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- April 14, 2016
- Completion date
- August 21, 2017
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.